SCHEMBL1609765

SCHEMBL1609765

COC(=O)c1nc(C2CC2)nc(N(C)c2ccc(OC)cc2OC)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
EGFR P00533 1/20 0.39
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
KDR P35968 1/20 0.39
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1611394 0.91 EGFR (0.40) HTTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL1610302 0.87 NTSR1 (0.38) NPC1RAB9ASMN1; SMN2TUBB4ATUBB
SCHEMBL2683026 0.85 EGFR (0.43) HTTEGFRPDGFRBPDGFRAKDR
SCHEMBL1610898 0.84 TUBB3 (0.55) EGFRPDGFRBKDRTUBB4ATUBB
SCHEMBL1610011 0.84 TUBB4A (0.42) HTTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL1610281 0.83 TUBB4A (0.41) HTTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL1610175 0.82 TUBB4A (0.38) HTTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL1609112 0.82 SLC6A3 (0.42) NPC1RAB9AHSD17B10KMT2ALMNA
SCHEMBL1609469 0.82 PDE4D (0.36) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL1610066 0.81 PDE4D (0.38) KMT2ATUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 HTT 1789/4885NPC1 3897/4885RAB9A 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.